Alcohol
Volume 20, Issue 3 , Pages 217-222 , April 2000

Gamma-hydroxybutyric acid Efficacy, potential abuse, and dependence in the treatment of alcohol addiction

  • Giovanni Addolorato

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • G. Fontana Center for the Study and Treatment of Alcohol Addiction, Università di Bologna, Bologna 40100, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39-6-3015-4334; fax: +39-6-3550-2775. E-mail address:(E. Capristo)
    • ,
  • Fabio Caputo

      Affiliations

    • G. Fontana Center for the Study and Treatment of Alcohol Addiction, Università di Bologna, Bologna 40100, Italy
    • ,
  • Esmeralda Capristo

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy
    • ,
  • G.Francesco Stefanini

      Affiliations

    • Department of Internal Medicine, Ospedale di Faenza, Faenza 48100, Italy
    • ,
  • Giovanni Gasbarrini

      Affiliations

    • Institute of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy

Received 15 May 1998 ,Accepted 1 June 1998.

References 

  1. Addolorato G, Stefanini GF, Casella G, Marsigli L, Caputo F, Gasbarrini G. Evaluation of the therapeutic efficacy of gamma-hydroxybutyric acid in the medium-term treatment of alcoholic outpatients (preliminary data from an open multicentric study). Alcologia Eur J Alcohol Stud. 1995;7:233–236
  2. Addolorato G, Castelli E, Stefanini GF, Casella G, Caputo F, Marsigli L, et al. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol. 1996;31:341–345
  3. Addolorato G, Stefanini GF, Gasbarrini G. Manageability and tolerability of gamma-hydroxybutyric acid in the medium-term outpatient treatment of alcoholism. Alcohol Clin Exp Res. 1997;21:380;a
  4. Addolorato G, Caputo F, Stefanini GF, Gasbarrini G. Gamma-hydroxybutyric acid in the treatment of alcohol dependence (possible craving development for the drug). Addiction. 1997;92:1041–1042b
  5. Addolorato G, Cibin M, Capristo E, Beghé F, Gessa GL, Stefanini GF, et al. Maintaining abstinence from alcohol by gamma-hydroxybutyric acid. Lancet. 1998;351:38;a
  6. Addolorato G, Stefanini GF, Gasbarrini G. Patients with alcohol problem. N Engl J Med. 1998;339:130;b
  7. Addolorato G, Cibin M, Caputo F, Capristo E, Gessa GL, Stefanini GF, et al. Gamma-hydroxybutyric acid in the treatment of alcoholism (dosage fractioning utility in non-responder alcoholic patients). Drug Alcohol Depend. 1998;53:7–10c
  8. Addolorato G, Caputo F, Capristo E, Bernardi M, Stefanini GF, Gasbarrini G. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment (utility of diazepam administration). Clin Neuropharmacol. 1999;22:60–62a
  9. Addolorato G, Capristo E, Gessa GL, Caputo F, Stefanini GF, Gasbarrini G. Long-term administration of GHB does not affect muscular mass in alcoholics. Life Sci. 1999;65:PL191–PL196b
  10. Agabio R, Colombo G, Loche A, Lobina C, Pani L, Reali R, et al. Gamma-hydroxybutyric acid reducing effect on ethanol intake (evidence in favour of a substitution mechanism). Alcohol Alcohol. 1998;33:1–10
  11. Anden N, Magnusson T, Stock G. Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gamma-hydroxybutyric acid. Arch Pharmacol. 1973;278:363–368
  12. Anonymous . GHB follows ketamine as UK rave scene embraces downer drugs. Druglink. 1994;9:5
  13. Carter J, Mofenson H, Carraccio T, Smith P, Morse D, Keys C, et al. Gamma-hydroxybutyrate use (New York and Texas, 1995–1996). Morb Mortal Wkly Rep. 1997;46:281–283
  14. Chin MY, Kreutzer RA, Dyer JB. Acute poisoning from gamma-hydroxybutyrate in California. West J Med. 1992;156:380–384
  15. Colombo G, Agabio R, Lobina C, Reali R, Fadda F, Gessa GL. Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol (occurrence within narrow dose ranges). Physiol Behav. 1995;57:105–111a
  16. Colombo G, Agabio R, Lobina C, Reali R, Fadda F, Gessa GL. Cross tolerance to ethanol and gamma-hydroxybutyric acid. Eur J Pharmacol. 1995;273:235–238b
  17. Colombo G, Agabio R, Diaz G, Fà M, Lobina C, Reali R, et al. Gamma-hydroxybutyric acid (GHB) intake in ethanol-preferring sP and -non preferring sNP rats. Physiol Behav. 1998;64:197–202
  18. Dall'Aglio C, Caputo F, Baudanza P, Castelli E, Marsigli L, Moscatello M, et al. Short and long-term treatment of alcohol dependence. Alcologia Eur J Alcohol Stud. 1997;9:61–64
  19. Di Bello MG, Gambassi F, Mugnai L, Masini E, Mannaioni PF. Gamma-hydroxybutyric acid induced suppression and prevention of alcohol withdrawal syndrome and relief of craving in alcohol dependent patients. Alcologia Eur J Alcohol Stud. 1995;7:9–16
  20. Dyer J. Gamma-hydroxybutyrate (a health food product producing coma and seizure-like activity). Am J Emerg Med. 1991;9:321–324
  21. Dyer J, Kreutzer RA, Quattrone A. Multistate outbreak of poisonings associated with illicit use of gamma-hydroxybutyrate. Morb Mortal Wkly Rep. 1990;39:861–863
  22. Edwards AGK, Rollnick S. Outcome studies of brief alcohol intervention in general practice (the problem of lost subjects). Addiction. 1997;92:1699–1704
  23. Erickson CK. Review of neurotransmitters and their role in alcoholism treatment. Alcohol Alcohol. 1996;31(suppl. 1):5–11
  24. Erickson, C. K., & O' Neill, J. T. (1995). It is time. National Council on Alcoholism and Drug Dependence Amethyst 3, Summer (pp. 1–2). New York: National Council on Alcoholism and Drug Dependence.
  25. Ferrara SD, Zotti S, Tedeschi L, Frison G, Castagna F, Gallimberti L, et al. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol. 1992;34:231–235
  26. Friedman J, Westlake R, Furman M. “Grievous bodily harm” (gamma-hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome). Neurology. 1996;46:460–471
  27. Gallimberti L, Canton G, Gentile N, Cibin M, Ferri M, Ferrara SD, et al. Gamma-hydroxybutyric acid for the treatment of alcohol withdrawal syndrome. Lancet. 1989;2:787–789
  28. Gallimberti L, Ferri M, Ferrara SD, Fadda F, Gessa GL. Gamma-hydroxybutyric acid in the treatment of alcohol dependence (a double blind study). Alcohol Clin Exp Res. 1992;16:673–676
  29. Galloway GP, Frederick SL, Staggers FE. Physical dependence on sodium oxybate. Lancet. 1994;342:57
  30. Galloway GP, Frederick SL, Staggers FE, Gonzales M, Stalcup SA, Smith DE. Gamma-hydroxybutyrate (an emerging drug of abuse that causes physical dependence). Addiction. 1997;92:89–96
  31. Gerra G, Marcato A, Fertonani Affini G, Avanzini P, Lechini R, Maestri D, et al. Gamma-hydroxybutyric acid (GHB) and neuroendocrine function in human. Neuroendocrinol Lett. 1994;16:55–63
  32. Gessa GL, Crabai F, Vargiu L, Spano PF. Selective increase of brain dopamine induced by gamma-hydroxybutyrate (study of the mechanism of action). J Neurochem. 1968;15:377–381
  33. Gessa GL, Agabio R, Carai MAM, Lobina C, Pani M, Reali R, et al. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. Alcohol. 2000;20:271–276
  34. Gianoulakis C. Implication of endogenous opioids and dopamine in alcoholism (human and basic science studies). Alcohol Alcohol. 1996;31(suppl. 1):33–42
  35. Kranzler HR, Anton RF. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. J Consult Clin Psychol. 1994;62:1116–1126
  36. Li J, Stokes SA, Woeckener A. A tale of novel intoxication (seven cases of gamma-hydroxybutyric acid overdose). Ann Emerg Med. 1998;31:723–728
  37. Louagie HK, Verstraete AG, De Soete CJ, Baetens DG, Calle P. A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol. J Toxicol Clin Toxicol. 1997;35:591–594
  38. Luby S, Jones J, Zalewski A. GHB use in South Carolina. Am J Pub Health. 1992;82:128
  39. Marwick C. Coma inducing drug GHB may be reclassified. J Am Med Assoc. 1997;277:1505–1506
  40. Meldrum B. GABA-agonist as anti-epileptic agent. Adv Biochem Psychopharmacol. 1981;26:207–217
  41. O'Connor PG, Schottenfeld RS. Patients with alcohol problem. N Engl J Med. 1998;338:592–602
  42. Poldrugo F, Addolorato G. The role of gamma-hydroxybutyric acid (GHB) in the treatment of alcoholism (from animal to clinical studies). Alcohol Alcohol. 1999;34:15–24
  43. Roth RH, Doherty JD, Walters JR. Gamma-hydroxybutyrate (a role in the regulation of central dopaminergic neurons). Brain Res. 1980;189:556–560
  44. Shapiro, H. (1994). Information for drug workers. Factsheet No. 8, GHB. London Institute for the study of drug dependence.
  45. Snead OC, Bearden LJ. Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate. Neurology. 1980;30:832–838
  46. Snead OC, Moreley BJ. Ontogeny of gamma-hydroxybutyric acid (regional concentration in developing rat, monkey and human brain). Brain Res. 1981;227:579–589
  47. Spano PF, Przegalinski E. Stimulation of serotonin synthesis by anaesthetic and nonanaesthetic doses of gamma-hydroxybutyrate. Pharmacol Res Commun. 1973;5:55–69
  48. Takahara J, Yunoki S, Yakushji W, Yamauchi J, Yamane Y, Ofuji T. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab. 1977;44:1014–1017
  49. Thomas G, Bonner S, Gascoigne A. Coma induced by abuse of gamma-hydroxybutyrate (GHB or liquid ecstasy) (a case report). Br Med J. 1997;314:35–36
  50. Tunnicliff G. Site of action of gamma-hydroxybutyrate (GHB) (a neuroactive drug with abuse potential). J Toxicol Clin Toxicol. 1997;35:581–590
  51. U.S. Food and Drug Administration . Warning about GHB. J Am Med Assoc. 1991;265:1802
  52. Vayer P, Mandel M, Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 1987;41:1547–1557
  53. Zolesi O, Daini L, Capone MR, Aglietti M, Raimondi F, Maremmani I. The use of GHB in anticraving therapy (preliminary experimental data of its use in alcohol and heroin dependence). In:  Tagliamonte A,  Maremmani I editor. Drug Addiction and Related Clinical Problems. Wien, New York: Springer-Verlag; 1994;p. 57–62

PII: S0741-8329(99)00084-1

Alcohol
Volume 20, Issue 3 , Pages 217-222 , April 2000

Article Tools